Our analysis found that TNF cluster A had lower TP53 mutation frequency compared to TNF cluster B. Another oncogenic driver gene in HNSCC tumor is EGFR, which was overexpressed in 80–90% of HNSCC tumors and was associated with poor overall survival and progression-free survival (31, 32). The gene discussed is EGFR; the disease is neoplasm.